相似文献
1
Vitamin K in Chronic Kidney Disease.
Nutrients. 2019 Jan 14;11(1):168. doi: 10.3390/nu11010168.
2
Emerging Role of Vitamins D and K in Modulating Uremic Vascular Calcification: The Aspect of Passive Calcification.
Nutrients. 2019 Jan 12;11(1):152. doi: 10.3390/nu11010152.
3
Role of Vitamin K in CKD: Is Its Supplementation Advisable in CKD Patients?
Kidney Blood Press Res. 2021;46(5):523-530. doi: 10.1159/000516611. Epub 2021 Jul 9.
4
Vitamin K deficiency: an emerging player in the pathogenesis of vascular calcification and an iatrogenic consequence of therapies in advanced renal disease.
Am J Physiol Renal Physiol. 2020 Oct 1;319(4):F618-F623. doi: 10.1152/ajprenal.00278.2020. Epub 2020 Aug 24.
5
Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease.
Kidney Int. 2013 May;83(5):835-44. doi: 10.1038/ki.2012.477. Epub 2013 Jan 23.
6
Vitamin K Deficiency in Chronic Kidney Disease: Evidence Is Building Up.
Am J Nephrol. 2017;45(1):1-3. doi: 10.1159/000451070. Epub 2016 Nov 15.
7
Low vitamin K1 intake in haemodialysis patients.
Clin Nutr. 2017 Apr;36(2):601-607. doi: 10.1016/j.clnu.2016.04.024. Epub 2016 Apr 28.
8
Vitamin K status in chronic kidney disease: a report of a study and a mini-review.
Int Urol Nephrol. 2013 Oct;45(5):1339-44. doi: 10.1007/s11255-012-0367-x. Epub 2013 Jan 8.
9
Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial.
J Am Soc Hypertens. 2017 Sep;11(9):589-597. doi: 10.1016/j.jash.2017.07.001. Epub 2017 Jul 13.
10
Vitamin K status in chronic kidney disease.
Nutrients. 2013 Nov 7;5(11):4390-8. doi: 10.3390/nu5114390.
引用本文的文献
1
Gla-Rich Protein Is Associated with Vascular Calcification, Inflammation, and Mineral Markers in Peritoneal Dialysis Patients.
J Clin Med. 2024 Dec 6;13(23):7429. doi: 10.3390/jcm13237429.
2
Global forecasting of chronic kidney disease mortality rates and numbers with the generalized additive model.
BMC Nephrol. 2024 Sep 2;25(1):286. doi: 10.1186/s12882-024-03720-w.
3
Anticoagulation in Chronic Kidney Disease.
Drugs. 2024 Oct;84(10):1199-1218. doi: 10.1007/s40265-024-02077-6. Epub 2024 Aug 9.
4
Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases.
Cell Death Differ. 2024 Sep;31(9):1104-1112. doi: 10.1038/s41418-024-01350-1. Epub 2024 Jul 27.
5
Beyond the Coagulation Cascade: Vitamin K and Its Multifaceted Impact on Human and Domesticated Animal Health.
Curr Issues Mol Biol. 2024 Jul 4;46(7):7001-7031. doi: 10.3390/cimb46070418.
6
Vitamin K: a potential missing link in critical illness-a scoping review.
Crit Care. 2024 Jul 1;28(1):212. doi: 10.1186/s13054-024-05001-2.
7
Vitamin K for Vascular Calcification in Kidney Patients: Still Alive and Kicking, but Still a Lot to Learn.
Nutrients. 2024 Jun 7;16(12):1798. doi: 10.3390/nu16121798.
8
Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
Exp Ther Med. 2023 Nov 23;27(1):30. doi: 10.3892/etm.2023.12318. eCollection 2024 Jan.
9
The efficacy and safety of direct factor Xa inhibitors versus vitamin K antagonists for atrial fibrillation in patients on hemodialysis: a meta-analysis of randomized controlled trials.
Proc (Bayl Univ Med Cent). 2023 Aug 21;36(6):736-743. doi: 10.1080/08998280.2023.2247958. eCollection 2023.
10
Effect of iron-fortified jamun leather on the Asunra-induced anemia in Sprague Dawley rats.
Front Nutr. 2023 Jun 13;10:1195981. doi: 10.3389/fnut.2023.1195981. eCollection 2023.
本文引用的文献
1
The role of kidney transplantation and phosphate binder use in vitamin K status.
PLoS One. 2018 Aug 30;13(8):e0203157. doi: 10.1371/journal.pone.0203157. eCollection 2018.
2
Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.
Circulation. 2018 Oct 9;138(15):1519-1529. doi: 10.1161/CIRCULATIONAHA.118.035418.
3
Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study.
BMC Nephrol. 2017 May 2;18(1):149. doi: 10.1186/s12882-017-0560-3.
4
Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis.
J Am Soc Nephrol. 2017 Jun;28(6):1717-1722. doi: 10.1681/ASN.2016060651. Epub 2017 Jan 3.
5
Vitamin K plasma levels determination in human health.
Clin Chem Lab Med. 2017 May 1;55(6):789-799. doi: 10.1515/cclm-2016-0783.
6
[Iron-based Phosphate Binders for ESRD Patients].
G Ital Nefrol. 2016 Jul-Aug;33(4).
7
Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials.
Am J Kidney Dis. 2016 Nov;68(5):691-702. doi: 10.1053/j.ajkd.2016.05.015. Epub 2016 Jul 22.
8
The Intriguing Correlation between Undercarboxylated Osteocalcin and Vitamin D.
J Med Assoc Thai. 2015 Sep;98 Suppl 8:S16-20.
9
Vitamin K antagonism aggravates chronic kidney disease-induced neointimal hyperplasia and calcification in arterialized veins: role of vitamin K treatment?
Kidney Int. 2016 Mar;89(3):601-11. doi: 10.1038/ki.2015.298.
10
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins.
Endocrine. 2016 Feb;51(2):333-41. doi: 10.1007/s12020-015-0673-z. Epub 2015 Jul 1.
Zotero 插件